BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 211206)

  • 1. Schwann cell abnormalities in 2,5-hexanedione neuropathy.
    Powell HC; Koch T; Garrett R; Lampert PW
    J Neurocytol; 1978 Aug; 7(4):517-28. PubMed ID: 211206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Giant axonal neuropathy: a childhood disorder of microfilaments.
    Koch T; Schultz P; Williams R; Lampert P
    Ann Neurol; 1977 May; 1(5):438-51. PubMed ID: 214018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schwann cell changes and demyelination in chronic galactose neuropathy.
    Powell HC; Myers RR
    Muscle Nerve; 1983; 6(3):218-27. PubMed ID: 6304510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental study on segmental demyelination in tellurium neuropathy.
    Takahashi T
    Hokkaido Igaku Zasshi; 1981 Mar; 56(2):105-31. PubMed ID: 6276282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An ultrastructural study of chronic cadmium chloride-induced neuropathy.
    Sato K; Iwamasa T; Tsuru T; Takeuchi T
    Acta Neuropathol; 1978 Mar; 41(3):185-90. PubMed ID: 206091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental lead neuropathy: a disease of the supporting cells in the peripheral nervous system.
    Schlaepfer WW
    J Neuropathol Exp Neurol; 1969 Jul; 28(3):401-18. PubMed ID: 4307024
    [No Abstract]   [Full Text] [Related]  

  • 7. Axonal degeneration in diphtheritic neuropathy.
    Bradley WG; Jennekens FG
    J Neurol Sci; 1971 Aug; 13(4):415-30. PubMed ID: 4328293
    [No Abstract]   [Full Text] [Related]  

  • 8. The response of the (myelinating) Schwann cell population to multiple episodes of demyelination.
    Hall SM
    J Neurocytol; 1983 Feb; 12(1):1-12. PubMed ID: 6302230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell body remodeling during dying-back axonopathy: DRG changes during advanced disease.
    Sterman AB
    J Neuropathol Exp Neurol; 1982 Jul; 41(4):400-11. PubMed ID: 6283036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gian axonal neuropathy--a generalized disorder of cytoplasmic microfilament formation.
    Prineas JW; Ouvrier RA; Wright RG; Walsh JC; McLeod JG
    J Neuropathol Exp Neurol; 1976 Jul; 35(4):458-70. PubMed ID: 180266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrastructural studies of the dying-back process. III. The evolution of experimental peripheral giant axonal degeneration.
    Spencer PS; Schaumburg HH
    J Neuropathol Exp Neurol; 1977; 36(2):276-99. PubMed ID: 190357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Supernumerary schwann cells during remyelination of regenerated and segmentally demyelinated axons in peripheral nerves].
    Schröder JM
    Verh Dtsch Ges Pathol; 1968; 52():222-8. PubMed ID: 4182232
    [No Abstract]   [Full Text] [Related]  

  • 13. Infantile chronic peripheral neuropathy with giant axons. Report of a case.
    Jedrzejowska H; Drac H
    Acta Neuropathol; 1977 Mar; 37(3):213-7. PubMed ID: 193342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrastructural studies of the dying-back process. V. Axonal neurofilaments accumulate at sites of 2,5-hexanedione application: evidence for nerve fibre dysfunction in experimental hexacarbon neuropathy.
    Politis MJ; Pellegrino RG; Spencer PS
    J Neurocytol; 1980 Aug; 9(4):505-16. PubMed ID: 7192310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental neuropathy produced by 2,5-hexanedione--a major metabolite of the neurotoxic industrial solvent methyl n-butyl ketone.
    Spencer PS; Schaumburg HH
    J Neurol Neurosurg Psychiatry; 1975 Aug; 38(8):771-5. PubMed ID: 171344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactive, degenerative, and proliferative Schwann cell responses in experimental galactose and human diabetic neuropathy.
    Kalichman MW; Powell HC; Mizisin AP
    Acta Neuropathol; 1998 Jan; 95(1):47-56. PubMed ID: 9452821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-stranded RNA induces iNOS gene expression in Schwann cells, sensory neuronal death, and peripheral nerve demyelination.
    Lee H; Park C; Cho IH; Kim HY; Jo EK; Lee S; Kho HS; Choi SY; Oh SB; Park K; Kim JS; Lee SJ
    Glia; 2007 May; 55(7):712-22. PubMed ID: 17348024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral neuropathy after exposure to methyl-isobutyl ketone in spray paint.
    AuBuchon J; Robins HI; Viseskul C
    Lancet; 1979 Aug; 2(8138):363-4. PubMed ID: 89425
    [No Abstract]   [Full Text] [Related]  

  • 19. Morphological study of peripheral nerve changes induced by chloroquine treatment.
    Tegnér R; Tomé FM; Godeau P; Lhermitte F; Fardeau M
    Acta Neuropathol; 1988; 75(3):253-60. PubMed ID: 2831692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schwann cell degeneration induced by doxorubicin (adriamycin).
    England JD; Rhee EK; Said G; Sumner AJ
    Brain; 1988 Aug; 111 ( Pt 4)():901-13. PubMed ID: 2840999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.